Nasher-Alneam v. United States

CourtDistrict Court, S.D. West Virginia
DecidedOctober 1, 2024
Docket2:21-cv-00360
StatusUnknown

This text of Nasher-Alneam v. United States (Nasher-Alneam v. United States) is published on Counsel Stack Legal Research, covering District Court, S.D. West Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nasher-Alneam v. United States, (S.D.W. Va. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF WEST VIRGINIA AT BLUEFIELD

MUHAMMED SAMER NASHER-ALNEAM,

Plaintiff,

v. CIVIL ACTION NO. 2:21-00360 (Criminal Action No. 2:18-00151)

UNITED STATES OF AMERICA,

Defendant.

MEMORANDUM OPINION AND ORDER By Standing Order, this action was referred to United States Magistrate Judge Cheryl A. Eifert for submission of findings and recommendations regarding disposition pursuant to 28 U.S.C. § 636(b)(1)(B). Magistrate Judge Eifert submitted to the court her Findings and Recommendation on May 16, 2022, in which she recommended that the district court grant defendant’s request for dismissal, deny Nasher-Alneam’s motion under 28 U.S.C. § 2255 and dismiss this matter from the court’s docket. In accordance with the provisions of 28 U.S.C. § 636(b), the parties were allotted fourteen days, plus three mailing days, in which to file any objections to Magistrate Judge Eifert’s Findings and Recommendation. The failure of any party to file such objections constitutes a waiver of such party's right to a de novo review by this court. Snyder v. Ridenour, 889 F.2d 1363 (4th Cir. 1989). Moreover, this court need not conduct a de novo review when a plaintiff “makes general and conclusory objections that do not direct the court to a specific error in the magistrate’s proposed findings and recommendations.” Orpiano v. Johnson, 687 F.2d 44, 47 (4th Cir. 1982). Nasher-Alneam filed objections to the PF&R. See ECF No.

352. He also filed a motion seeking an enlargement of time to supplement his objections. See ECF No. 353. That motion is GRANTED and the court has considered ECF No. 354 (Memorandum of Law in Support of Objections). Approximately a month later, Nasher-Alneam filed another motion seeking additional time to supplement the record with the case of Ruan v. United States, 142 S. Ct. 2370 (2022). That motion is GRANTED insofar as the court has considered Ruan. I. Background Nasher-Alneam was a medical doctor licensed to practice medicine in the State of West Virginia. See ECF No. 223 at ¶ 1 (Third Superseding Indictment). From on or about July 2013

through February 2018, Dr. Nasher-Alneam owned and operated a medical practice called "Neurology & Pain Center, PLLC," located in Kanawha County, West Virginia. Id. at ¶¶ 2-3. During the relevant time period, Dr. Nasher-Alneam had an active Drug Enforcement Administration (DEA) registration number that allowed him to prescribe controlled substances, including

2 Schedule II, III, IV, and V controlled substances. See id. at ¶ 8. On July 26, 2018, a federal grand jury returned a 15-count indictment against Nasher-Alneam arising out of his activities in connection with Neurology & Pain Center, PLLC. See ECF No.

1. A second superseding indictment was returned on November 21, 2018, charging defendant with illegal drug distributions, in violation of 21 U.S.C. § 841(a)(1); illegal drug distributions resulting in death, in violation of 21 U.S.C. § 841(a)(1) and (b)(1)(C); maintaining a drug-involved premises, in violation of 21 U.S.C. § 856(a)(1); and international money laundering, in violation of 18 U.S.C. § 1956(a)(2)(B)(ii). Trial on the second superseding indictment began on April 16, 2019. After the jury was unable to reach a verdict on any of the twenty-two counts, a mistrial was declared on May 7, 2019. Defendant invoked his rights under the Speedy Trial Act and the retrial was scheduled for July 22, 2019

After the declaration of a mistrial, on June 12, 2019, Nasher-Alneam was charged in a forty-seven count third superseding indictment charging him with various offenses related to operation of his medical practice. Specifically, defendant was charged with the following:

3 1) health care fraud, in violation of 18 U.S.C. § 1347 and § 2 (Counts One through Eleven and Fifteen through Twenty-four);

2) health care fraud resulting in death, in violation of 18 U.S.C. § 1347 and § 2 (Counts Twelve through Fourteen);

3) illegal drug distributions, in violation of 21 U.S.C. § 841(a)(1) (Counts Twenty-five through Thirty-eight);

4) illegal drug distributions resulting in death, in violation of 21 U.S.C. § 841(a)(1) and (b)(1)(C) (Counts Thirty-nine through Forty-one);

5) maintaining a drug-involved premises, in violation of 21 U.S.C. § 856(a)(1) (Counts Forty- two and Forty-three); and

6) international money laundering, in violation of 18 U.S.C. § 1956(a)(2)(B)(ii) (Counts Forty-four through Forty-seven).1

See ECF No. 223. Pursuant to a written plea agreement with the United States, Nasher-Alneam pled guilty to Count 25 of the third superseding indictment charging him with illegal distribution of a controlled substance, in violation of 21 U.S.C. § 841(a)(1). See ECF No. 291. As to the factual basis for the plea, Nasher- Alneam agreed that: On or about July 15, 2014, at or near South Charleston, Kanawha County, West Virginia, I provided

1 The court granted defendant’s motion for judgment of acquittal as to the money laundering counts and the corresponding counts in the third superseding indictment were dismissed. See ECF No. 231.

4 a prescription to patient B.N., for 90 10 mg methadone pills, a Schedule II controlled substance. I did not maintain any medical record for patient B.N. nor did I document any justification as to the legitimate medical purpose for distributing the controlled substance. For these reasons, this distribution was not within the bounds of professional medical practice or for a legitimate medical purpose.

On or about July 23, 2014, at or near South Charleston, Kanawha County, West Virginia, I provided a second prescription to patient B.N., this time for 120 30 mg oxycodone pills, a Schedule II controlled substance. Again, I did not maintain any medical record for patient B.N. nor did I document any justification as to the legitimate medical purpose for distributing the controlled substance. For these reasons, this distribution was not within the bounds of professional medical practice or for a legitimate medical purpose.

While the B.N. identified in each prescription described above was the same person, B.N.’s last name was spelled differently on the first prescription and a different date of birth was listed.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Padilla v. Kentucky
559 U.S. 356 (Supreme Court, 2010)
United States v. Howle
166 F.3d 1166 (Eleventh Circuit, 1999)
Blackledge v. Allison
431 U.S. 63 (Supreme Court, 1977)
Strickland v. Washington
466 U.S. 668 (Supreme Court, 1984)
Hill v. Lockhart
474 U.S. 52 (Supreme Court, 1985)
Roe v. Flores-Ortega
528 U.S. 470 (Supreme Court, 2000)
Slack v. McDaniel
529 U.S. 473 (Supreme Court, 2000)
Miller-El v. Cockrell
537 U.S. 322 (Supreme Court, 2003)
Harrington v. Richter
131 S. Ct. 770 (Supreme Court, 2011)
Snyder v. Ridenour
889 F.2d 1363 (Fourth Circuit, 1989)
Ramani Pilla v. United States
668 F.3d 368 (Sixth Circuit, 2012)
Rose v. Lee
252 F.3d 676 (Fourth Circuit, 2001)
United States v. Edgar Sterling Lemaster
403 F.3d 216 (Fourth Circuit, 2005)
United States v. Rogelio Serrano-Lara
698 F.3d 841 (Fifth Circuit, 2012)
United States v. Timothy Fugit
703 F.3d 248 (Fourth Circuit, 2012)
Gregory Christian v. David Ballard
792 F.3d 427 (Fourth Circuit, 2015)
United States v. Gerald Boutcher
998 F.3d 603 (Fourth Circuit, 2021)
Xiulu Ruan v. United States
597 U.S. 450 (Supreme Court, 2022)

Cite This Page — Counsel Stack

Bluebook (online)
Nasher-Alneam v. United States, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nasher-alneam-v-united-states-wvsd-2024.